Search

A retrospective study of patients with distal rectal cancer at Memorial Sloan Kettering Cancer Center (MSK) has found a higher rate of local recurrence after intersphincteric resection with handsewn coloanal anastomosis (ISR-CAA) than with abdominoperineal resection (APR) in patients without a clinical response to neoadjuvant therapy who underwent total mesorectal excision (TME).

… Wednesday, March 19, 2025 A retrospective study of patients with distal rectal cancer at Memorial Sloan Kettering Cancer Center (MSK) has found a higher rate of local recurrence after intersphincteric resection with handsewn coloanal anastomosis (ISR-CAA) than with abdominoperineal resection (APR) in

A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia.

… Monday, February 20, 2017 Summary Researchers are reporting that they’ve used stem cells to create a new kind of model for studying myelodysplastic syndromes and acute myeloid leukemia in the laboratory. Highlights This is the first time researchers have been able to replicate each stage of the disease

Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 disease.

… Tuesday, December 10, 2019 Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 (cN1) disease. Further, abnormal axillary lymph nodes on MRI should

Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging, artificial intelligence in cancer imaging, and for his pioneering work in the development and validation of novel imaging biomarkers in oncology.

… Wednesday, November 16, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.

… Tuesday, July 26, 2022 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by  U.S. News & World Report  in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently

The research was published in the New England Journal of Medicine and presented at the American Society of Hematology (ASH) Annual Meeting and Exposition.

… Tuesday, December 14, 2021 A study from Memorial Sloan Kettering Cancer Center (MSK) published today in the New England Journal of Medicine (NEJM) , found that in patients with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) Polatuzumab vedotin with Rituximab, Cyclophosphamide, Doxorubicin

Older, vulnerable patients with relapsed/refractory large B cell lymphoma should receive the same consideration for CAR T cell therapy as younger patients.

… Friday, April 3, 2020 Older, vulnerable patients with relapsed/refractory large B cell lymphoma (LBCL) should receive the same consideration for chimeric antigen receptor (CAR) T cell therapy as younger patients, according to our study published recently online and ahead of print in the journal Haematologica

The recommendation comes in the form of draft guidelines open for public comment until October 2019.

… Wednesday, August 28, 2019 Summary The FDA is recommending that men with breast cancer be included in clinical trials of breast cancer medicines. Male breast cancer is very rare — less than 1% of breast cancer cases in the U.S. occur in men. Historically, men have been excluded from breast cancer clinical

A blood-based test identifies patients in whom immunotherapy may ‘LAG.’

… Wednesday, August 25, 2021 In recent years, immune-based treatments for cancer have buoyed the hopes of doctors and patients alike. Drugs called immune checkpoint inhibitors have provided lifesaving benefits to a growing list of people with several types of cancer, including melanoma , lung cancer ,

Tomya Watt is recognized as a Notable Black Leader in today’s Crain’s New York Business special editorial feature. This piece spotlights exceptional Black individuals from various industries who have had a positive impact on New York City through their professional, communal, and philanthropic achievements.

… Monday, February 21, 2022 Tomya Watt is recognized as a Notable Black Leader in today’s Crain’s New York Business special editorial feature. This piece spotlights exceptional Black individuals from various industries who have had a positive impact on New York City through their professional, communal